Showing 1 - 10 of 10
Thonburi Health, Chula to study hemp
Business, Lamonphet Apisitniran, Published on 06/04/2021
» SET-listed Thonburi Healthcare Group (THG) will allocate a 300-million-baht budget to a joint venture with Chulalongkorn University to study the medical benefits of hemp, cannabis and krathom in a move to develop commercial products by this year.
MPI rises 6.6% in January to reach 10-month high
Business, Lamonphet Apisitniran, Published on 01/03/2023
» Thailand's Manufacturing Production Index (MPI) increased by 6.6% from December last year to reach 99.8 points in January, the highest level in 10 months, thanks to more business activity, driven by an uptick in tourism.
Innobic in talks with potential partner
Business, Lamonphet Apisitniran, Published on 02/09/2022
» Innobic (Asia) Co, the life science arm of national oil and gas conglomerate PTT Plc, is seeking a new business partner in Iceland in a fresh move to produce medicines to treat cancer.
BIS banking on CBD products for animals
Business, Lamonphet Apisitniran, Published on 19/08/2022
» Cannabis and hemp-derived cannabidiol (CBD) has the potential to boost the pet care business, following the first-ever development of new CBD-based products for animals in Thailand, says Bioscience Animal Health Plc (BIS), an animal drug and vaccine provider.
JSP poised to ramp up CBD oil production
Business, Lamonphet Apisitniran, Published on 06/06/2022
» JSP Pharmaceutical Manufacturing (Thailand) plans to increase production of cannabidiol (CBD) oil, extracted from cannabis and hemp, to 30,000 kilogrammes by the second half, up from 300kg, to serve demand for CBD mixtures in products ranging from food to cosmetics.
A sector with an agenda
Business, Lamonphet Apisitniran, Published on 02/05/2022
» The 2022 meetings of the Apec Business Advisory Council (Abac), which highlights the bio-, circular and green (BCG) economic model, are prompting Thailand to gear up for advanced technologies and environmentally friendly businesses.
BIS preparing to raise funds via IPO in mid-2022
Business, Lamonphet Apisitniran, Published on 04/12/2021
» Bioscience Animal Health Plc (BIS), an animal drug and vaccine provider, is preparing to raise funds through an initial public offering on the Stock Exchange of Thailand in mid-2022 to support the development of a new pig vaccine in Thailand.
Bioscience lines up 3 new drugs
Business, Lamonphet Apisitniran, Published on 19/02/2020
» Thai pharmaceutical maker Siam Bioscience Group plans to produce and sell three new drugs for complicated diseases -- cancer, kidney failure and autoimmune diseases -- by 2022 both domestically and abroad.
BH allots B4bn for upgrade as competition intensifies
Business, Lamonphet Apisitniran, Published on 04/10/2019
» SET-listed Bumrungrad International Hospital (BH) has earmarked 4 billion baht over the next five years (2019-2023) towards operations, ward renovations, IT and medical equipment to increase efficiency and provide better services to patients.
Price controls 'will hit healthcare'
Business, Lamonphet Apisitniran, Published on 15/01/2019
» The Private Hospital Association is calling for the state to bring all public hospitals under the jurisdiction of the Medical Facilities Act of 1988 in response to the government's proposed price controls on medical services.